BmeRABC5 is a multidrug efflux system that can confer metronidazole resistance in Bacteroides fragilis

Microbial Drug Resistance

Volumn 13, Issue 2, 2007, Pages 96-101

  Pumbwe, Lilian ^a,b   Chang, Abraham ^a   Smith, Rachel L ^a   Wexler, Hannah M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Wadsworth Anaerobe Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CEFOPERAZONE; CEFOXITIN; CIPROFLOXACIN; DODECYL SULFATE SODIUM; ETHIDIUM BROMIDE; HYBRID PROTEIN; IMIPENEM; MEMBRANE PROTEIN; METRONIDAZOLE; PROTEIN BMERABC5; SPACER DNA; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM MUTANT; BACTEROIDES FRAGILIS; BMEA5 GENE; BMEB5 GENE; BMEC5 GENE; CELL INCLUSION; GENE DELETION; GENE OVEREXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REGULATOR GENE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTEROIDES FRAGILIS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING;

BACTEROIDES FRAGILIS; ESCHERICHIA COLI;

EID: 34547561708     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2007.719     Document Type: Article

References (15)

1. Alekshun, M.N., Y.S. Kim, and S.B. Levy. 2000. Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding. Mol. Microbiol. 35:1394-1404.
2. Baughn, A.D., and M.H. Malamy. 2002. A mitochondrial-like aconitase in the bacterium Bacteroides fragilis: implications for the evolution of the mitochondrial Krebs cycle. Proc. Natl. Acad. Sci. USA 99:4662-4667.
3. Brazier, J.S., S.L. Stubbs, and B.I. Duerden. 1999. Metronidazole resistance among clinical isolates belonging to the Bacteroides fragilis group: time to be concerned? J. Antimicrob. Chemother. 44:580-581.
4. Carlier, J.P., N. Sellier, M.N. Rager, and G. Reysset. 1997. Metabolism of a 5-nitroimidazole in susceptible and resistant isogenic strains of Bacteroides fragilis. Antimicrob. Agents Chemother. 41:1495-1499.
5. Chuanchuen, R., J.B. Gaynor, R. Karkhoff-Schweizer, and H.P. Schweizer. 2005. Molecular characterization of MexL, the transcriptional repressor of the mexJK multidrug efflux operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:1844-1851.
6. Hedberg, M., and C.E. Nord. 2003. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clin. Microbiol. Infect. 9:475-488.
7. Lin, J., M. Akiba, O. Shahin, and Q. Zhang. 2005. CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob. Agents Chemother. 49:1067-1075.
8. Lorfmark, S., H. Fang, M. Hedberg, and C. Edlund. 2005. Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates. Antimicrob. Agents Chemother. 49:1253-1256.
9. Sánchez, P., A. Alonso, and J.L. Martinez. 2002. Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. Antimicrob. Agents Chemother. 46:3386-3393.
10. Schaumann, R., S. Petzold, and A.C. Rodloff. 2005. Inducible metronidazole resistance in nim-positive and nim-negative Bacteroides fragilis group strains after several passages metronidazole containing Columbia agar plates. Infection 33:368-372.
11. Stubbs, S.L., J.S. Brazier, P.R. Talbot, and B.I. Duerden. 2000. PCR-restriction fragment length polymorphism analysis for identification of Bacteroides spp. and characterization of nitroimidazole resistance genes. J. Clin. Microbiol. 38:3209-3213.
12. Pumbwe, L., O. Ueda, F. Yoshimura, A. Chang, R.L. Smith, and H.M. Wexler. 2006. Bacteroides fragilis BmeABC efflux systems additively confer intrinsic antimicrobial resistance. J. Antimicrob. Chemother. 58:37-46.
13. Pumbwe, L., D. Glass, and H.M. Wexler. 2006. Efflux pump overexpression in multiple-antibiotic-resistant mutants of Bacteroides fragilis. Antimicrob. Agents Chemother. 50:3150-3153.
14. Ueda, O., H.M. Wexler, K. Hirai, Y. Shibata, F. Yoshimura, and S. Fujimura. 2005. Sixteen homologs of the mex-type multidrug resistance efflux pump in Bacteroides fragilis. Antimicrob. Agents Chemother. 49:2807-2815.
15. Wexler, H.M., E. Molitoris, F. Jashnian, and S.M. Finegold. 1991. Comparison of spiral gradient with conventional agar dilution for susceptibility testing of anaerobic bacteria. Antimicrob. Agents Chemother. 35:1196-1202.